SCHEMBL29597315

SCHEMBL29597315

Fc1cc(OCc2ccccc2)ccc1Br

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 10/20 0.57
▸ ALOX5 P09917 1/20 0.56
▸ LCK P06239 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ PTGS1 P23219 1/20 0.50
▸ SLC6A2 P23975 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ PTGS2 P35354 1/20 0.50
▸ SLC6A3 Q01959 1/20 0.50
▸ HIF1A Q16665 1/20 0.50
▸ HDAC6 Q9UBN7 1/20 0.50
▸ MAOA P21397 3/20 0.49
▸ GAA P10253 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ PARP15 Q460N3 1/20 0.48
▸ PARP10 Q53GL7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL320455 1.00 MAOB (0.57) MAOBALOX5LCKLMNACYP1A2
SCHEMBL8616533 0.89 GSTP1 (0.48) MAOBALOX5LCKMAOACTSV
SCHEMBL8613875 0.89 GSTP1 (0.48) MAOBALOX5LCKMAOACTSV
SCHEMBL8618479 0.89 GSTP1 (0.48) MAOBALOX5LCKMAOACTSV
SCHEMBL8614981 0.87 GSTP1 (0.53) MAOBALOX5LCKLMNACYP1A2
SCHEMBL15688265 0.87 MAOB (0.44) MAOBALOX5LCKLMNACYP1A2
SCHEMBL8616319 0.87 GSTP1 (0.53) MAOBALOX5LCKLMNACYP1A2
SCHEMBL8614759 0.86 GSTP1 (0.49) MAOBALOX5MAOAMAPTCTSV
SCHEMBL8251097 0.86 MAOB (0.57) MAOBALOX5LMNACYP1A2PTGS1
SCHEMBL30065009 0.86 MAOB (0.57) MAOBALOX5LMNACYP1A2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025224599-A1 PYRROLIDINE-BASED GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF PFIZER INC. (US) 2025-10-30 — — WO disclosed
WO-2025137605-A1 COMPOUNDS FOR TARGETED DEGRADATION OF PROTO-ONCOGENE TYROSINE PROTEIN KINASE RECEPTOR C4 THERAPEUTICS, INC. (US) 2025-06-26 — — WO disclosed
WO-2025096589-A1 PRMT5 INHIBITORS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2025-05-08 — — WO disclosed
CN-119823124-A Compounds for targeted degradation of BRD9 C4医药公司 2025-04-15 — — CN disclosed
CN-119546577-A Modulators of G protein-coupled receptor 88 阿卡蒂亚药品公司 2025-02-28 — — CN disclosed
CN-119403782-A Modulators of G protein-coupled receptor 88 阿卡蒂亚药品公司 2025-02-07 — — CN disclosed
CN-115279370-B Compounds for targeted degradation of BRD9 C4医药公司 2025-01-10 — — CN disclosed
WO-2024220917-A1 PRMT5 INHIBITORS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2024-10-24 — — WO disclosed
CN-118307534-A LTA4H inhibitors and uses thereof 上海海雁医药科技有限公司 2024-07-09 — — CN disclosed
CN-114349737-B Sulfonamide structure-containing compound and application thereof, and pharmaceutical composition and application thereof 南京烁慧医药科技有限公司 2023-06-09 — — CN disclosed
CN-115279370-A Compounds for targeted degradation of BRD9 C4医药公司 2022-11-01 — — CN disclosed
CN-114349737-A Compound containing sulfonamide structure and application thereof, and pharmaceutical composition and application thereof 南京烁慧医药科技有限公司 2022-04-15 — — CN disclosed
Send feedback